Legal Representation
Attorney
Stewart Bellus
USPTO Deadlines
Next Deadline
823 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-11-02)
Due Date
November 02, 2027
Grace Period Ends
May 02, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 2, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 25, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 24, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 23, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 23, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 13, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 13, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 11, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 16, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 16, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 5, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 3, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 28, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 27, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 22, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Botanical extracts containing quercetin and derived from quercetin for pharmaceutical and medical use; pharmaceutical preparations containing quercetin for the treatment of cardiovascular system diseases, urinary system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, central nervous system diseases, locomotor apparatus diseases, skin diseases and for the treatment of painful conditions; and nutritional supplements containing quercetin
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Additional Information
Design Mark
The mark consists of the term "QUERCEFIT" with letters in the same stylized font, except for the "F" which is larger and thicker than the other letters, in a lighter shade of black, and diagonal blank lines at the bottom and middle of the letter.
Classification
International Classes
005